Literature DB >> 2384598

Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. II. Determination of molecular genetic origins of rearrangements.

J Conboy1, S Marchesi, R Kim, P Agre, Y W Kan, N Mohandas.   

Abstract

Protein 4.1 is an approximately 80-kD structural protein in the membrane skeleton which underlies and supports the erythrocyte plasma membrane. The preceding companion paper presents a biochemical study of two abnormal protein 4.1 species from individuals with the red blood cell disorder, hereditary elliptocytosis. These variants, "protein 4.1(68/65)" and "protein 4.1(95)," have altered molecular weights due to internal deletions and duplications apparently localized around the spectrin-actin binding domain. Here we use polymerase chain reaction (PCR) techniques to clone and sequence the corresponding mutant reticulocyte mRNAs, and correlate the deletion/duplication end points with exon boundaries of the gene. Protein 4.1(68/65) mRNA lacks sequences encoding the functionally important spectrin-actin binding domain due to a 240 nucleotide (nt) deletion spanning the codons for Lys407-Gly486. Protein 4.1(95) mRNA encodes a protein with two spectrin-actin binding domains by virtue of a 369 nt duplication of codons for Lys407-Gln529. These deletions and duplications correspond to gene rearrangements involving three exons encoding 21, 59, and 43 amino acids, respectively. The duplicated 21 amino acid exon in the 4.1(95) gene retains its proper tissue-specific expression pattern, being spliced into reticulocyte 4.1 mRNA and out of lymphocyte 4.1 mRNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384598      PMCID: PMC296755          DOI: 10.1172/JCI114739

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  HEREDITARY ELLIPTOCYTOSIS: GENETIC LINKAGE WITH THE RH CHROMOSOME.

Authors:  V A LOVRIC; R J WALSH; M A BRADLEY
Journal:  Australas Ann Med       Date:  1965-05

2.  Direct cloning and sequence analysis of enzymatically amplified genomic sequences.

Authors:  S J Scharf; G T Horn; H A Erlich
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

3.  Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia.

Authors:  M A Lehrman; J L Goldstein; D W Russell; M S Brown
Journal:  Cell       Date:  1987-03-13       Impact factor: 41.582

4.  Selective expression of an erythroid-specific isoform of protein 4.1.

Authors:  T K Tang; T L Leto; I Correas; M A Alonso; V T Marchesi; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  The heterozygous form of 4.1(-) hereditary elliptocytosis [the 4.1(-) trait].

Authors:  N Alloisio; L Morlé; E Dorléac; O Gentilhomme; D Bachir; D Guetarni; P Colonna; M Bost; Z Zouaoui; L Roda
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

6.  Erythrocyte spectrin is comprised of many homologous triple helical segments.

Authors:  D W Speicher; V T Marchesi
Journal:  Nature       Date:  1984 Sep 13-19       Impact factor: 49.962

7.  A structural model of human erythrocyte protein 4.1.

Authors:  T L Leto; V T Marchesi
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

8.  Molecular cloning of protein 4.1, a major structural element of the human erythrocyte membrane skeleton.

Authors:  J Conboy; Y W Kan; S B Shohet; N Mohandas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  Molecular basis of hereditary elliptocytosis due to protein 4.1 deficiency.

Authors:  J Conboy; N Mohandas; G Tchernia; Y W Kan
Journal:  N Engl J Med       Date:  1986-09-11       Impact factor: 91.245

10.  Authentic beta-globin mRNA sequences in homozygous betaO-thalassemia.

Authors:  G F Temple; J C Chang; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more
  6 in total

1.  Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene.

Authors:  N Dalla Venezia; F Gilsanz; N Alloisio; M T Ducluzeau; E J Benz; J Delaunay
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Spectrin Rouen (beta 220-218), a novel shortened beta-chain variant in a kindred with hereditary elliptocytosis. Characterization of the molecular defect as exon skipping due to a splice site mutation.

Authors:  M Garbarz; W T Tse; P G Gallagher; C Picat; M C Lecomte; F Galibert; D Dhermy; B G Forget
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Differentiation-associated switches in protein 4.1 expression. Synthesis of multiple structural isoforms during normal human erythropoiesis.

Authors:  J A Chasis; L Coulombel; J Conboy; S McGee; K Andrews; Y W Kan; N Mohandas
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

4.  Protein 4.1 R-135 interacts with a novel centrosomal protein (CPAP) which is associated with the gamma-tubulin complex.

Authors:  L Y Hung; C J Tang; T K Tang
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

5.  An isoform-specific mutation in the protein 4.1 gene results in hereditary elliptocytosis and complete deficiency of protein 4.1 in erythrocytes but not in nonerythroid cells.

Authors:  J G Conboy; J A Chasis; R Winardi; G Tchernia; Y W Kan; N Mohandas
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

6.  The transcription factor, Nuclear factor, erythroid 2 (Nfe2), is a regulator of the oxidative stress response during Danio rerio development.

Authors:  Larissa M Williams; Briony A Lago; Andrew G McArthur; Amogelang R Raphenya; Nicholas Pray; Nabil Saleem; Sophia Salas; Katherine Paulson; Roshni S Mangar; Yang Liu; Andy H Vo; Jordan A Shavit
Journal:  Aquat Toxicol       Date:  2016-10-01       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.